Abstract
The potent angiotensin-converting enzyme (ACE) inhibitor 351 A was radioiodinated ( 125I-351A) and used to quantitate ACE in the striatum of rats treated with the cholinergic neurotoxin AF64A. Unilateral administration of 4nmol of AF64A into the striatum, which caused a 42% reduction in striatal choline acetyltransferase (ChAT) activity, reduced binding of 125I-351A in the lesioned striatum by 37% relative to the untreated striatum. The AF64A treatment also reduced the dopamine (DA) concentration by 59% in the lesioned striatum, but did not significantly reduce the serotonin (5-HT) concentration. Despite the reductions in ACE and these neurochemical markers, there was no significant correlation between the extent of reduction of the specific neurochemical markers and ACE. These results suggest that the AF64A treatment caused non-specific damage to striatal non-cholinergic neurons as well as destroying cholinergic neurons, and that ACE is contained in non-cholinergic neurons.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
